ArticleBMJ open2025

Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial.

Maxime Teisseyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.